Current Research Interest
Dr. Samorodnitsky’s research interests are in developing statistical methods for multi-omic and spatial omics datasets with the goal of identifying biomarkers of disease outcomes. Her research has spanned integrative matrix factorization methods, spatial point process models, and topological data analysis. She is also interested in novel clinical trial designs motivated by challenges in oncology research. Dr. Samorodnitsky collaborates with clinical investigators in the Bone Marrow Transplant Service and the Cell Therapy Service to address clinical and translational research questions.
Selected peer-reviewed publications:
- Samorodnitsky, S., Campbell, K., Ribas, A., & Wu, M. C. (2024). A SPatial Omnibus Test (SPOT) for Spatial Proteomic Data. Bioinformatics, 40(7), btae425.
- Samorodnitsky, S., Campbell, K., Little, A., Ling, W., Zhao, N., Chen, Y. C., & Wu, M. C. (2024). Detecting Clinically Relevant Topological Structures in Multiplexed Spatial Proteomics Imaging Using TopKAT. bioRxiv.
- Samorodnitsky, S., Othus, M., LeBlanc, M., & Wu, M. C. (2024). Reverse Selection Designs for Accommodating Multiple Control Arms. Clinical Cancer Research, 30(24), 5535-5539.
- Samorodnitsky, S., & Wu, M. C. (2024). Statistical Analysis of Multiple Regions-of-Interest in Multiplexed Spatial Proteomics Data. Briefings in Bioinformatics, 25(6), bbae522.
- Samorodnitsky, S., Wendt, C. H., & Lock, E. F. (2024). Bayesian Simultaneous Factorization and Prediction Using Multi-Omic Data. Computational Statistics & Data Analysis, 197, 1079
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Sarah Samorodnitsky discloses the following relationships and financial interests:
-
American Urological Association
Professional Services and Activities
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2025 through disclosure submission in spring 2026). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures